Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study (vol 39, 1068, 2022)

被引：0
|
作者：
Ghislain, Pierre-Dominique [1 ]
Lambert, Jo [2 ]
Hoai, Xuan-Lan Lam [3 ]
Hillary, Tom [4 ]
Roquet-Gravy, Pierre-Paul [5 ]
de la Brassinne, Michel [6 ]
Segaert, Siegfried
机构：
[1] Univ Hosp St Luc, Dept Dermatol, Ave Hippocrate 10, B-1200 Brussels, Belgium
[2] Ghent Univ Hosp, Dept Dermatol, Ghent, Belgium
[3] Univ Hosp St Pierre, Dept Dermatol, Brussels, Belgium
[4] Univ Hosp Leuven, Dept Dermatol, Leuven, Belgium
[5] Grand Hop Charleroi, Dept Dermatol, Charleroi, Belgium
[6] CHU Liege, Dept Dermatol, Liege, Belgium
来源：
ADVANCES IN THERAPY | 2023年 / 40卷 / 07期
关键词：
D O I：
10.1007/s12325-023-02542-w
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：3279 / 3280
页数：2
相关论文
共 50 条
  • [1] Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study
    Pierre-Dominique Ghislain
    Jo Lambert
    X. L. Lam Hoai
    Tom Hillary
    Pierre-Paul Roquet-Gravy
    Michel de la Brassinne
    Siegfried Segaert
    Advances in Therapy, 2022, 39 : 1068 - 1080
  • [2] Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study
    Ghislain, Pierre-Dominique
    Lambert, Jo
    Hoai, Xuan-Lan Lam
    Hillary, Tom
    Roquet-Gravy, Pierre-Paul
    de la Brassinne, Michel
    Segaert, Siegfried
    ADVANCES IN THERAPY, 2022, 39 (02) : 1068 - 1080
  • [3] Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study
    Pierre-Dominique Ghislain
    Jo Lambert
    Xuãn-Lan Lam Hoai
    Tom Hillary
    Pierre-Paul Roquet-Gravy
    Michel de la Brassinne
    Siegfried Segaert
    Advances in Therapy, 2023, 40 : 3279 - 3280
  • [4] Place of apremilast in the real-life treatment of patients with plaque psoriasis
    Gisondi, P.
    Geat, D.
    Girolomoni, G.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (01) : 13 - 13
  • [5] Effectiveness of Apremilast in Real Life in Patients with Psoriasis: A Longitudinal Study
    Malara, Giovanna
    Politi, Cristina
    Trifiro, Caterina
    Verduci, Chiara
    D'Arrigo, Graziella
    Testa, Alessandra
    Tripepi, Giovanni
    ACTA DERMATO-VENEREOLOGICA, 2021, 101
  • [6] Treatment adherence: a hurdle for real-life effectiveness in psoriasis?
    Reich, K.
    Dauden, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 : 1 - 3
  • [7] Management of primary biliary cholangitis: results from a large real-life observational study in France and Belgium
    Pariente, Alexandre
    Chazouilleres, Olivier
    Causse, Xavier
    Hanslik, Bertrand
    Arpurt, Jean-Pierre
    Henrion, Jean
    Rosa, Isabelle
    Renou, Christophe
    Garioud, Armand
    Corpechot, Christophe
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E197 - E205
  • [8] Management of primary biliary cholangitis: results from a large real-life observational study in France and Belgium
    Pariente, Alexandre
    Chazouilleres, Olivier
    Causse, Xavier
    Hanslik, Bertrand
    Arpurt, Jean-Pierre
    Henrion, Jean
    Rosa, Isabelle
    Renou, Christophe
    Garioud, Armand
    Corpechot, Christophe
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E197 - E205
  • [9] Apremilast as a target therapy for nail psoriasis: a real-life observational study proving its efficacy in restoring the nail unit
    Lanna, C.
    Cesaroni, G. M.
    Mazzilli, S.
    Vollono, L.
    Gaziano, R.
    Marino, D.
    Bianchi, L.
    Campione, E.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) : 1097 - 1101
  • [10] An observational study of the real-life management of psoriasis patients treated with etanercept according to the new reimbursement criteria (in Belgium)
    Segaert, Siegfried
    Ghislain, Pierre-Dominique
    Boone, Caroline
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (02) : 103 - 109
12345